References
[1] Zhong, W., Sladek, F. M., Darnell, J. E., Jr., The expression
pattern of a Drosophila homolog to the mouse transcription factor HNF-4
suggests a determinative role in gut formation. EMBO J 1993,12 , 537-544.
[2] Chen, W. S., Manova, K., Weinstein, D. C., Duncan, S. A.,
et al. , Disruption of the HNF-4 gene, expressed in visceral endoderm,
leads to cell death in embryonic ectoderm and impaired gastrulation of
mouse embryos. Genes Dev 1994, 8 , 2466-2477.
[3] Duncan, S. A., Manova, K., Chen, W. S., Hoodless, P., et
al. , Expression of transcription factor HNF-4 in the extraembryonic
endoderm, gut, and nephrogenic tissue of the developing mouse embryo:
HNF-4 is a marker for primary endoderm in the implanting blastocyst.Proc Natl Acad Sci U S A 1994, 91 , 7598-7602.
[4] Xanthopoulos, K. G., Prezioso, V. R., Chen, W. S., Sladek, F.
M., et al. , The different tissue transcription patterns of genes
for HNF-1, C/EBP, HNF-3, and HNF-4, protein factors that govern
liver-specific transcription. Proc Natl Acad Sci U S A 1991,88 , 3807-3811.
[5] Taraviras, S., Monaghan, A. P., Schutz, G., Kelsey, G.,
Characterization of the mouse HNF-4 gene and its expression during mouse
embryogenesis. Mech Dev 1994, 48 , 67-79.
[6] Drewes, T., Senkel, S., Holewa, B., Ryffel, G. U., Human
hepatocyte nuclear factor 4 isoforms are encoded by distinct and
differentially expressed genes. Mol Cell Biol 1996, 16 ,
925-931.
[7] Hayhurst, G. P., Lee, Y. H., Lambert, G., Ward, J. M., Gonzalez,
F. J., Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is
essential for maintenance of hepatic gene expression and lipid
homeostasis. Mol Cell Biol 2001, 21 , 1393-1403.
[8] Parviz, F., Matullo, C., Garrison, W. D., Savatski, L., et
al. , Hepatocyte nuclear factor 4alpha controls the development of a
hepatic epithelium and liver morphogenesis. Nat Genet 2003,34 , 292-296.
[9] Wortham, M., Czerwinski, M., He, L., Parkinson, A., Wan, Y. J.,
Expression of constitutive androstane receptor, hepatic nuclear factor 4
alpha, and P450 oxidoreductase genes determines interindividual
variability in basal expression and activity of a broad scope of
xenobiotic metabolism genes in the human liver. Drug Metab Dispos2007, 35 , 1700-1710.
[10] Bartoov-Shifman, R., Hertz, R., Wang, H., Wollheim, C.
B., et al. , Activation of the insulin gene promoter through a
direct effect of hepatocyte nuclear factor 4 alpha. J Biol Chem2002, 277 , 25914-25919.
[11] Wang, H., Maechler, P., Antinozzi, P. A., Hagenfeldt, K. A.,
Wollheim, C. B., Hepatocyte nuclear factor 4alpha regulates the
expression of pancreatic beta -cell genes implicated in glucose
metabolism and nutrient-induced insulin secretion. J Biol Chem2000, 275 , 35953-35959.
[12] Miura, A., Yamagata, K., Kakei, M., Hatakeyama, H., et
al. , Hepatocyte nuclear factor-4alpha is essential for
glucose-stimulated insulin secretion by pancreatic beta-cells. J
Biol Chem 2006, 281 , 5246-5257.
[13] Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., et
al. , Mutations in the hepatocyte nuclear factor-4alpha gene in
maturity-onset diabetes of the young (MODY1). Nature 1996,384 , 458-460.
[14] Ellard, S., Colclough, K., Mutations in the genes encoding the
transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4
alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat2006, 27 , 854-869.
[15] Colclough, K., Bellanne-Chantelot, C., Saint-Martin, C.,
Flanagan, S. E., Ellard, S., Mutations in the genes encoding the
transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in
maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.Hum Mutat 2013, 34 , 669-685.
[16] Moore, B. D., Khurana, S. S., Huh, W. J., Mills, J. C.,
Hepatocyte nuclear factor 4alpha is required for cell differentiation
and homeostasis in the adult mouse gastric epithelium. Am J
Physiol Gastrointest Liver Physiol 2016, 311 , G267-275.
[17] Garrison, W. D., Battle, M. A., Yang, C., Kaestner, K.
H., et al. , Hepatocyte nuclear factor 4alpha is essential for
embryonic development of the mouse colon. Gastroenterology 2006,130 , 1207-1220.
[18] Ahn, S. H., Shah, Y. M., Inoue, J., Morimura, K., et
al. , Hepatocyte nuclear factor 4alpha in the intestinal epithelial
cells protects against inflammatory bowel disease. Inflamm Bowel
Dis 2008, 14 , 908-920.
[19] Darsigny, M., Babeu, J. P., Dupuis, A. A., Furth, E. E.,
et al. , Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion
transport and causes chronic inflammation resembling inflammatory bowel
disease in mice. PLoS One 2009, 4 , e7609.
[20] Yeh, M. M., Bosch, D. E., Daoud, S. S., Role of hepatocyte
nuclear factor 4-alpha in gastrointestinal and liver diseases.World J Gastroenterol 2019, 25 , 4074-4091.
[21] Yang, X., Coulombe-Huntington, J., Kang, S., Sheynkman, G.
M., et al. , Widespread Expansion of Protein Interaction
Capabilities by Alternative Splicing. Cell 2016, 164 ,
805-817.
[22] Babeu, J. P., Boudreau, F., Hepatocyte nuclear factor 4-alpha
involvement in liver and intestinal inflammatory networks. World J
Gastroenterol 2014, 20 , 22-30.
[23] Wang, Z., Zhang, Y., Zhang, J., Deng, Q., Liang, H.,
Controversial roles of hepatocyte nuclear receptor 4 alpha on
tumorigenesis. Oncol Lett 2021, 21 , 356.
[24] Sladek, F. M., Zhong, W. M., Lai, E., Darnell, J. E., Jr.,
Liver-enriched transcription factor HNF-4 is a novel member of the
steroid hormone receptor superfamily. Genes Dev 1990, 4 ,
2353-2365.
[25] Pawlak, M., Lefebvre, P., Staels, B., General molecular biology
and architecture of nuclear receptors. Curr Top Med Chem 2012,12 , 486-504.
[26] Sladek, F. M., Ruse, M. D., Jr., Nepomuceno, L., Huang, S. M.,
Stallcup, M. R., Modulation of transcriptional activation and
coactivator interaction by a splicing variation in the F domain of
nuclear receptor hepatocyte nuclear factor 4alpha1. Mol Cell Biol1999, 19 , 6509-6522.
[27] Kritis, A. A., Argyrokastritis, A., Moschonas, N. K., Power,
S., et al. , Isolation and characterization of a third isoform of
human hepatocyte nuclear factor 4. Gene 1996, 173 ,
275-280.
[28] Argyrokastritis, A., Kamakari, S., Kapsetaki, M., Kritis,
A., et al. , Human hepatocyte nuclear factor-4 (hHNF-4) gene maps
to 20q12-q13.1 between PLCG1 and D20S17. Hum Genet 1997,99 , 233-236.
[29] Thomas, H., Jaschkowitz, K., Bulman, M., Frayling, T. M.,
et al. , A distant upstream promoter of the HNF-4alpha gene connects the
transcription factors involved in maturity-onset diabetes of the young.Hum Mol Genet 2001, 10 , 2089-2097.
[30] Huang, J., Levitsky, L. L., Rhoads, D. B., Novel P2
promoter-derived HNF4alpha isoforms with different N-terminus generated
by alternate exon insertion. Exp Cell Res 2009, 315 ,
1200-1211.
[31] Lambert, E., Babeu, J. P., Simoneau, J., Raisch, J., et
al. , Human Hepatocyte Nuclear Factor 4-alpha Encodes Isoforms with
Distinct Transcriptional Functions. Mol Cell Proteomics 2020,19 , 808-827.
[32] Ko, H. L., Zhuo, Z., Ren, E. C., HNF4alpha Combinatorial
Isoform Heterodimers Activate Distinct Gene Targets that Differ from
Their Corresponding Homodimers. Cell Rep 2019, 26 ,
2549-2557 e2543.
[33] Furuta, H., Iwasaki, N., Oda, N., Hinokio, Y., et al. ,
Organization and partial sequence of the hepatocyte nuclear factor-4
alpha/MODY1 gene and identification of a missense mutation, R127W, in a
Japanese family with MODY. Diabetes 1997, 46 , 1652-1657.
[34] Hata, S., Tsukamoto, T., Osumi, T., A novel isoform of rat
hepatocyte nuclear factor 4 (HNF-4). Biochim Biophys Acta 1992,1131 , 211-213.
[35] Hata, S., Inoue, T., Kosuga, K., Nakashima, T., et al. ,
Identification of two splice isoforms of mRNA for mouse hepatocyte
nuclear factor 4 (HNF-4). Biochim Biophys Acta 1995, 1260 ,
55-61.
[36] Chartier, F. L., Bossu, J. P., Laudet, V., Fruchart, J. C.,
Laine, B., Cloning and sequencing of cDNAs encoding the human hepatocyte
nuclear factor 4 indicate the presence of two isoforms in human liver.Gene 1994, 147 , 269-272.
[37] Nakhei, H., Lingott, A., Lemm, I., Ryffel, G. U., An
alternative splice variant of the tissue specific transcription factor
HNF4alpha predominates in undifferentiated murine cell types.Nucleic Acids Res 1998, 26 , 497-504.
[38] Sladek, F. M., Shawn, D., Seidel, S. D., in: McCabe, E. R. B.,
Burris, T. P. (Eds.), Nuclear receptors and genetic disease ,
Academic Press, London 2001, pp. 309-361.
[39] Tanaka, T., Jiang, S., Hotta, H., Takano, K., et al. ,
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear
factor-4alpha in the pathogenesis of human cancer. J Pathol 2006,208 , 662-672.
[40] Torres-Padilla, M. E., Fougere-Deschatrette, C., Weiss, M. C.,
Expression of HNF4alpha isoforms in mouse liver development is regulated
by sequential promoter usage and constitutive 3’ end splicing.Mech Dev 2001, 109 , 183-193.
[41] Hansen, S. K., Parrizas, M., Jensen, M. L., Pruhova, S.,
et al. , Genetic evidence that HNF-1alpha-dependent transcriptional
control of HNF-4alpha is essential for human pancreatic beta cell
function. J Clin Invest 2002, 110 , 827-833.
[42] Eeckhoute, J., Moerman, E., Bouckenooghe, T., Lukoviak,
B., et al. , Hepatocyte nuclear factor 4 alpha isoforms originated
from the P1 promoter are expressed in human pancreatic beta-cells and
exhibit stronger transcriptional potentials than P2 promoter-driven
isoforms. Endocrinology 2003, 144 , 1686-1694.
[43] Jiang, S., Tanaka, T., Iwanari, H., Hotta, H., et al. ,
Expression and localization of P1 promoter-driven hepatocyte nuclear
factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl Recept2003, 1 , 5.
[44] Harries, L. W., Locke, J. M., Shields, B., Hanley, N. A.,
et al. , The diabetic phenotype in HNF4A mutation carriers is moderated
by the expression of HNF4A isoforms from the P1 promoter during fetal
development. Diabetes 2008, 57 , 1745-1752.
[45] Briancon, N., Weiss, M. C., In vivo role of the HNF4alpha AF-1
activation domain revealed by exon swapping. EMBO J 2006,25 , 1253-1262.
[46] Chellappa, K., Deol, P., Evans, J. R., Vuong, L. M., et
al. , Opposing roles of nuclear receptor HNF4alpha isoforms in colitis
and colitis-associated colon cancer. Elife 2016, 5 .
[47] Babeu, J. P., Darsigny, M., Lussier, C. R., Boudreau, F.,
Hepatocyte nuclear factor 4alpha contributes to an intestinal epithelial
phenotype in vitro and plays a partial role in mouse intestinal
epithelium differentiation. Am J Physiol Gastrointest Liver
Physiol 2009, 297 , G124-134.
[48] Babeu, J. P., Jones, C., Geha, S., Carrier, J. C., Boudreau,
F., P1 promoter-driven HNF4alpha isoforms are specifically repressed by
beta-catenin signaling in colorectal cancer cells. J Cell Sci2018, 131 .
[49] Pascussi, J. M., Robert, A., Moreau, A., Ramos, J., et
al. , Differential regulation of constitutive androstane receptor
expression by hepatocyte nuclear factor4alpha isoforms.Hepatology 2007, 45 , 1146-1153.
[50] Vuong, L. M., Chellappa, K., Dhahbi, J. M., Deans, J. R.,
et al. , Differential Effects of Hepatocyte Nuclear Factor 4alpha
Isoforms on Tumor Growth and T-Cell Factor 4/AP-1 Interactions in Human
Colorectal Cancer Cells. Mol Cell Biol 2015, 35 ,
3471-3490.
[51] Kistanova, E., Dell, H., Tsantili, P., Falvey, E., et
al. , The activation function-1 of hepatocyte nuclear factor-4 is an
acidic activator that mediates interactions through bulky hydrophobic
residues. Biochem J 2001, 356 , 635-642.
[52] Green, V. J., Kokkotou, E., Ladias, J. A., Critical structural
elements and multitarget protein interactions of the transcriptional
activator AF-1 of hepatocyte nuclear factor 4. J Biol Chem 1998,273 , 29950-29957.
[53] Torres-Padilla, M. E., Weiss, M. C., Effects of interactions of
hepatocyte nuclear factor 4alpha isoforms with coactivators and
corepressors are promoter-specific. FEBS Lett 2003, 539 ,
19-23.
[54] Dasgupta, S., Lonard, D. M., O’Malley, B. W., Nuclear receptor
coactivators: master regulators of human health and disease. Annu
Rev Med 2014, 65 , 279-292.
[55] Malik, S., Karathanasis, S. K., TFIIB-directed transcriptional
activation by the orphan nuclear receptor hepatocyte nuclear factor 4.Mol Cell Biol 1996, 16 , 1824-1831.
[56] Soutoglou, E., Katrakili, N., Talianidis, I., Acetylation
regulates transcription factor activity at multiple levels. Mol
Cell 2000, 5 , 745-751.
[57] Dell, H., Hadzopoulou-Cladaras, M., CREB-binding protein is a
transcriptional coactivator for hepatocyte nuclear factor-4 and enhances
apolipoprotein gene expression. J Biol Chem 1999, 274 ,
9013-9021.
[58] Torres-Padilla, M. E., Sladek, F. M., Weiss, M. C.,
Developmentally regulated N-terminal variants of the nuclear receptor
hepatocyte nuclear factor 4alpha mediate multiple interactions through
coactivator and corepressor-histone deacetylase complexes. J Biol
Chem 2002, 277 , 44677-44687.
[59] Kim, H. J., Lee, S. K., Na, S. Y., Choi, H. S., Lee, J. W.,
Molecular cloning of xSRC-3, a novel transcription coactivator from
Xenopus, that is related to AIB1, p/CIP, and TIF2. Mol Endocrinol1998, 12 , 1038-1047.
[60] Lee, Y. K., Dell, H., Dowhan, D. H., Hadzopoulou-Cladaras, M.,
Moore, D. D., The orphan nuclear receptor SHP inhibits hepatocyte
nuclear factor 4 and retinoid X receptor transactivation: two mechanisms
for repression. Mol Cell Biol 2000, 20 , 187-195.
[61] Ruse, M. D., Jr., Privalsky, M. L., Sladek, F. M., Competitive
cofactor recruitment by orphan receptor hepatocyte nuclear factor
4alpha1: modulation by the F domain. Mol Cell Biol 2002,22 , 1626-1638.
[62] Xie, Y. B., Nedumaran, B., Choi, H. S., Molecular
characterization of SMILE as a novel corepressor of nuclear receptors.Nucleic Acids Res 2009, 37 , 4100-4115.
[63] Yoshida, E., Aratani, S., Itou, H., Miyagishi, M., et
al. , Functional association between CBP and HNF4 in trans-activation.Biochem Biophys Res Commun 1997, 241 , 664-669.
[64] Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., et
al. , Control of hepatic gluconeogenesis through the transcriptional
coactivator PGC-1. Nature 2001, 413 , 131-138.
[65] Daigo, K., Kawamura, T., Ohta, Y., Ohashi, R., et al. ,
Proteomic analysis of native hepatocyte nuclear factor-4alpha
(HNF4alpha) isoforms, phosphorylation status, and interactive cofactors.J Biol Chem 2011, 286 , 674-686.
[66] Centore, R. C., Sandoval, G. J., Soares, L. M. M., Kadoch, C.,
Chan, H. M., Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging
Mechanisms and Therapeutic Strategies. Trends Genet 2020,36 , 936-950.
[67] Wanior, M., Kramer, A., Knapp, S., Joerger, A. C., Exploiting
vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer
therapy. Oncogene 2021, 40 , 3637-3654.
[68] Orlando, K. A., Nguyen, V., Raab, J. R., Walhart, T., Weissman,
B. E., Remodeling the cancer epigenome: mutations in the SWI/SNF complex
offer new therapeutic opportunities. Expert Rev Anticancer Ther2019, 19 , 375-391.
[69] Maeda, Y., Rachez, C., Hawel, L., 3rd, Byus, C. V., et
al. , Polyamines modulate the interaction between nuclear receptors and
vitamin D receptor-interacting protein 205. Mol Endocrinol 2002,16 , 1502-1510.
[70] Malik, S., Wallberg, A. E., Kang, Y. K., Roeder, R. G.,
TRAP/SMCC/mediator-dependent transcriptional activation from DNA and
chromatin templates by orphan nuclear receptor hepatocyte nuclear factor
4. Mol Cell Biol 2002, 22 , 5626-5637.
[71] Soutourina, J., Transcription regulation by the Mediator
complex. Nat Rev Mol Cell Biol 2018, 19 , 262-274.
[72] Schiano, C., Casamassimi, A., Rienzo, M., de Nigris, F.,
et al. , Involvement of Mediator complex in malignancy. Biochim
Biophys Acta 2014, 1845 , 66-83.
[73] Mattera, L., Escaffit, F., Pillaire, M. J., Selves, J.,
et al. , The p400/Tip60 ratio is critical for colorectal cancer cell
proliferation through DNA damage response pathways. Oncogene2009, 28 , 1506-1517.
[74] Basta, J., Rauchman, M., The nucleosome remodeling and
deacetylase complex in development and disease. Transl Res 2015,165 , 36-47.
[75] Lai, A. Y., Wade, P. A., Cancer biology and NuRD: a
multifaceted chromatin remodelling complex. Nat Rev Cancer 2011,11 , 588-596.